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A BS T R AC T
Background

It is unclear whether an evaluation incorporating coronary computed tomographic
angiography (CCTA) is more effective than standard evaluation in the emergency
department in patients with symptoms suggestive of acute coronary syndromes.
Methods

In this multicenter trial, we randomly assigned patients 40 to 74 years of age with
symptoms suggestive of acute coronary syndromes but without ischemic electrocardiographic changes or an initial positive troponin test to early CCTA or to standard
evaluation in the emergency department on weekdays during daylight hours between
April 2010 and January 2012. The primary end point was length of stay in the hospital. Secondary end points included rates of discharge from the emergency department, major adverse cardiovascular events at 28 days, and cumulative costs. Safety
end points were undetected acute coronary syndromes.
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Results

The rate of acute coronary syndromes among 1000 patients with a mean (±SD) age
of 54±8 years (47% women) was 8%. After early CCTA, as compared with standard
evaluation, the mean length of stay in the hospital was reduced by 7.6 hours
(P<0.001) and more patients were discharged directly from the emergency department (47% vs. 12%, P<0.001). There were no undetected acute coronary syndromes
and no significant differences in major adverse cardiovascular events at 28 days.
After CCTA, there was more downstream testing and higher radiation exposure.
The cumulative mean cost of care was similar in the CCTA group and the standardevaluation group ($4,289 and $4,060, respectively; P = 0.65).
Conclusions

In patients in the emergency department with symptoms suggestive of acute
coronary syndromes, incorporating CCTA into a triage strategy improved the efficiency of clinical decision making, as compared with a standard evaluation in the
emergency department, but it resulted in an increase in downstream testing and
radiation exposure with no decrease in the overall costs of care. (Funded by the
National Heart, Lung, and Blood Institute; ROMICAT-II ClinicalTrials.gov number,
NCT01084239.)
n engl j med 367;4
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reatment of patients with acute
chest pain but an inconclusive initial evaluation with the use of biomarkers and electrocardiographic (ECG) testing is often diagnostically challenging and inefficient. The majority of
patients with acute coronary syndromes have under
lying coronary artery disease.1 Contrast-enhanced
coronary computed tomographic angiography
(CCTA) has high sensitivity and specificity for the
detection of clinically significant coronary artery
disease, as compared with invasive coronary angiography, in patients in stable condition with suspected or known coronary artery disease.2-5
Rule Out Myocardial Infarction/Ischemia Using
Computer Assisted Tomography (ROMICAT-I),6 a
blinded observational study involving patients in
the emergency department with suspected acute
coronary syndromes, and other studies7,8 have
shown that normal findings on CCTA have a very
high negative predictive value for ruling out acute
coronary syndromes during the index hospitalization and the occurrence of major adverse cardiovascular events over the next 2 years.7,9 The results
of two previous randomized, multicenter trials10,11
suggest that CCTA may facilitate safe and earlier
triage of low-risk patients and that CCTA can rule
out coronary artery disease faster than stress
myocardial-perfusion imaging. However, imaging
the coronary anatomy with CCTA can involve more
procedures and greater costs than functional testing.12 Thus, equipoise exists regarding the effectiveness of incorporating CCTA into an evaluation
strategy in the emergency department.
The objectives of this study were to compare
the effectiveness of a CCTA-based evaluation strategy with that of standard evaluation in the emergency department for patients with symptoms
suggestive of an acute coronary syndrome and to
evaluate the downstream testing, cost, and radiation exposure associated with CCTA.

Me thods
Study Design and Oversight

ROMICAT-II was designed as a randomized, controlled, multicenter trial in which an evaluation and
management strategy that included CCTA as a
first diagnostic test performed as early as possible
was compared with a standard emergency department evaluation for patients with acute chest
pain suggestive of an acute coronary syndrome.
After random assignments had been made to ini300
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tial CCTA or standard evaluation without CCTA,
patient care in both groups was not mandated by
the study protocol but instead was at the discretion
of local physicians. The design of ROMICAT-II
has been described in detail previously,13 and the
study protocol is available with the full text of
this article at NEJM.org.
Study Population

Patient enrollment began on April 23, 2010, and
ended on January 30, 2012, at nine hospitals in
the United States. All patients provided written
informed consent to participate in the study. Eligibility criteria were chosen according to the
ROMICAT-I study,6 with the goal of enrolling a
population with a similar prevalence of acute
coronary syndromes (approximately 8%). Eligible
patients were 40 to 74 years of age, presented to
the emergency department with chest pain (or
the anginal equivalent) of at least 5 minutes’ duration within 24 hours before presentation in the
emergency department, were in sinus rhythm,
and warranted further risk stratification to rule
out acute coronary syndromes, as determined by
an attending physician in the emergency department. Major exclusion criteria were a history of
known coronary artery disease, new diagnostic
ischemic changes on the initial ECG, an initial
troponin level in excess of the 99th percentile of
the local assay, impaired renal function (creatinine level, >1.5 mg per deciliter [132.6 µmol per
liter]), hemodynamic or clinical instability, known
allergy to an iodinated contrast agent, a bodymass index (the weight in kilograms divided by
the square of the height in meters) greater than
40, or currently symptomatic asthma.
Study Protocol

Eligible patients were identified, provided written
informed consent, and were randomly assigned
at their initial evaluation in the emergency department during weekday daytime hours. Patients were
randomly assigned in a 1:1 ratio to either CCTA
as part of the initial evaluation in the emergency
department or the standard evaluation strategy
in the emergency department at that site. All test
results were provided to emergency department
physicians in real time. Additional care was not
mandated by the study protocol in either randomization group.
The discharge diagnosis was based on the local physicians’ assessment. The discharge diag-
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noses were adjudicated separately by a clinical
end-points committee in a predefined sample of
242 patients, which included all patients with
acute coronary syndromes, the first 8 patients
enrolled at each site, 4% of patients discharged
with cardiac symptoms, and a randomly selected
subgroup of 10% of all patients. The definitions
of acute coronary syndromes are provided in the
Supplementary Appendix, available at NEJM.org.
To ascertain potentially undetected acute coronary syndromes and as a safety measure, patients
discharged within 24 hours after presentation in
the emergency department were contacted by telephone within 72 hours to assess their clinical status. A follow-up telephone call to all patients was
also conducted 28 days after discharge. During
telephone calls, information on repeat visits to
the emergency department or rehospitalizations
for recurrent chest pain (including diagnostic
testing, interventions, and clinical events during
follow-up) was obtained and verified by the collection of medical records.

1273 Patients were assessed for eligibility

273 Were excluded
228 Declined to participate
45 Had administrative
reasons

1000 Underwent randomization

501 Were assigned to CCTA (473 [94%]
underwent CCTA as a first test)

499 Were assigned to standard
evaluation in emergency department

497 (99%) Were included
in 28-day follow-up

490 (98%) Were included
in 28-day follow-up

Figure 1. Screening, Randomization, and Follow-up of the Study Patients.
CCTA denotes coronary computed tomographic angiography.

CCTA

Before the start of the study, participating sites
were not routinely performing CCTA in patients
in the emergency department to detect acute coronary syndromes, but they were required to use
at least 64-slice CT technology for patient assessment. Protocols involving both retrospectively
ECG-gated and prospectively ECG-triggered CCTA
were permitted, with use according to published
guidelines.14 The use of tube modulation to lower
radiation exposure was strongly encouraged. CCTA
images were interpreted on-site in real time, and
the results were communicated to the responsible
clinician.
End Points

The prespecified primary end point was the length
of the hospital stay, defined as the time from
presentation in the emergency department to the
time of the discharge order. This end point was
chosen because it reflects the summary of actions
taken in response to clinical information and test
results, as well as logistical, cost, and medical
and legal considerations in participating centers.
Secondary effectiveness end points included the
time to diagnosis, defined as the time from presentation in the emergency department until the
first diagnostic test that led to the diagnosis of an
acute coronary syndrome, or as the time from
n engl j med 367;4

presentation in the emergency department to the
final test that was used to rule out an acute coronary syndrome. The rate of direct discharge from
the emergency department was defined as the
proportion of patients discharged from the emergency department without admission to an observation unit or the hospital. Resource utilization
was defined as any diagnostic testing (CCTA, exercise treadmill testing, nuclear imaging, stress
echocardiography, or cardiac catheterization) or
interventions from the index assessment in the
emergency department to follow-up at 28 days, and
it included resources used during repeat visits to
the emergency department or hospitalization for
recurrent chest pain. Cumulative radiation exposure was defined as radiation exposure from
testing, including CCTA, nuclear perfusion imaging, and invasive coronary angiography, measured in millisieverts and calculated with the
use of standard methods15 during the index care
episode (the visit to the emergency department
and hospitalization) and follow-up. Health care
costs during the index care episode were assessed
from reports from hospital cost-accounting systems and physician billing records and were adjusted to 2011 dollars. Mean costs for patient care,
diagnostic testing, and interventions during the
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index care episode were used to estimate the
costs during follow-up.
Safety variables prespecified as secondary
end points included an undetected acute coronary syndrome (defined as an unexpected cardiovascular event within 72 hours after hospital
discharge in patients with a hospital stay of <24
hours), to ensure that potentially earlier discharge
in the CCTA group was not associated with increased adverse events, major adverse cardiovascular events (defined as death, myocardial infarction, unstable angina, or urgent coronary
revascularization within 28 days), and periprocedural complications (stroke, bleeding, anaphylaxis,
or renal failure). These predefined safety variables
were adjudicated by an external, independent
clinical-events committee.

are presented as means ±SD and medians with
interquartile ranges. Comparisons between groups
were performed with the use of an independentsample t-test for continuous variables, Fisher’s
exact test for categorical variables, and the Wilcoxon rank-sum test for ordinal variables. A twosided P value of less than 0.05 was considered to
indicate statistical significance. Concordance between the discharge diagnosis made at the study
site and the independently adjudicated diagnosis
in a selected subpopulation was assessed with
the use of the kappa statistic.
The study was designed to have greater than
83% power with the use of a t-test at a two-sided
5% significance level if the true between-group
difference in the length of stay in the hospital was
at least 8.3 hours. Details of the simulation are
described elsewhere.13
Statistical Analyses
The study did not have predefined stopping
All statistical analyses were performed by an in- rules or boundaries with respect to the primary
dependent data coordinating center on the basis end point or safety end points. Rather, the data
of an intention-to-treat analysis. Continuous data and safety monitoring board was responsible for
Table 1. Baseline Demographic and Clinical Characteristics of the Patients.*

Variable
Mean age — yr
Female sex — %

CCTA
(N = 501)

Standard
Evaluation
(N = 499)

P Value

54±8

54±8

0.44

48

46

0.57

Race or ethnic group — no. (%)
Black

141 (28)

141 (28)

1.00

White

330 (66)

330 (66)

0.95

Asian

18 (4)

13 (23)

0.47

Other
Non-Hispanic

12 (2)

18 (4)

0.27

435 (87)

422 (85)

0.57

269 (54)

272 (54)

0.80

Cardiovascular risk factors — no. (%)
Hypertension
Diabetes mellitus

86 (17)

87 (17)

0.93

Dyslipidemia

230 (46)

224 (45)

0.75

Former or current smoker

249 (50)

243 (49)

0.75

Family history of premature coronary artery disease

135 (27)

136 (27)

0.94

0 or 1

36

38

2 or 3

54

52

≥4

10

10

115 (23)

113 (23)

0.94

88 (18)

82 (16)

0.67

143 (28)

151 (30)

0.58

No. of cardiovascular risk factors — %

0.68

Relevant prior medication — no. (%)
Aspirin
Beta-blocker
Statin
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Table 1. (Continued.)

Variable

CCTA
(N = 501)

Standard
Evaluation
(N = 499)

444 (89)

452 (91)

P Value

Initial presentation in emergency department
Chief symptom — no. (%)

0.47

Radiating or nonradiating chest pain or anginal equivalent
Arm, jaw, shoulder, or epigastric pain
Shortness of breath
Other

21 (4)

16 (3)

7 (1)

10 (2)

29 (6)

21 (4)

78±14

77±14

Systolic

144±23

144±23

0.80

Diastolic

83±13

83±13

0.94

29.4±5.3

29.1±4.8

Heart rate — beats/min

0.58

Blood pressure — mm Hg

BMI
Discharge diagnosis after index emergency department visit or hospitalization — no. (%)
Noncardiac chest pain
Noncoronary cardiac pain

426 (85)

445 (89)

7 (1)

8 (2)

Coronary chest pain not associated with acute coronary syndrome

25 (5)

14 (3)

Acute coronary syndrome

43 (9)

32 (6)

35 (7)

17 (3)

8 (2)

15 (3)

Unstable angina pectoris
Myocardial infarction

0.41
0.16

* Plus–minus values are means ±SD. BMI denotes body-mass index (the weight in kilograms divided by the square of the
height in meters), and CCTA coronary computed tomographic angiography.

assessing every case in which an acute coronary site and independent adjudication for the discharge
syndrome might have been undetected.
diagnosis was very high (concordance, 98% [236 of
242 patients]; kappa, 0.94).

R e sult s
Study Population

Primary and Secondary Effectiveness
End Points

Of 1000 enrolled patients, 501 were randomly assigned to CCTA and 499 were randomly assigned
to a standard evaluation in the emergency department. All patients were included in the intentionto-treat analysis (Fig. 1). CCTA was not performed
in 28 patients (6%) because of the patient’s decision to decline CCTA (9 patients), safety concerns
(5 patients), unavailability of CCTA (5 patients),
or technical difficulties (9 patients). Overall, 987 of
1000 randomly assigned patients (99%) had complete follow-up at 28 days. The original medical
records for repeat visits to the emergency department or hospitalizations were available in all cases.
Baseline characteristics of the study population
are shown in Table 1. After a complete evaluation, 75 patients (8%) had a final diagnosis of an
acute coronary syndrome. Agreement between the

The effectiveness end points are shown in Table 2.
The primary end point met the prespecified criterion for significance, since the average length of
the hospital stay in the group of patients randomly assigned to CCTA was decreased by 7.6
hours, as compared with the group randomly assigned to a standard emergency department evaluation (P<0.001). Figure 2 shows the cumulative
distribution of discharged patients with lengthof-stay data in the two groups. Notably, 50% of
the patients in the CCTA group were discharged
within 8.6 hours after presentation, as compared
with 10% of the patients randomly assigned to a
standard evaluation in the emergency department. In the subgroup of patients with a final
diagnosis of an acute coronary syndrome, the
length of stay in the hospital was similar after
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Table 2. Primary and Secondary Effectiveness and Safety End Points.*

End Point

CCTA
(N = 501)

Standard
Evaluation
(N = 499)

23.2±37.0

30.8±28.0

8.6

26.7

6.4–27.6

21.4–30.6

17.2±24.6

27.2±19.5

P Value

Length of hospital stay — hr
All patients in intention-to-treat analysis

<0.001

Mean
Median
Interquartile range
Patients with final diagnosis other than acute coronary syndrome
Mean
Median
Interquartile range

<0.001
8.1

26.3

6.2–24.6

20.6–29.5

86.3±72.3

83.8±61.3

Patients with final diagnosis of acute coronary syndrome

0.87

Mean
Median
Interquartile range

56.9

71.8

46.2–95.9

45.2–96.7

10.4±12.6

18.7±11.8

Time to diagnosis — hr
All patients in intention-to-treat analysis

<0.001

Mean
Median
Interquartile range

5.8

21.0

4.0–9.0

8.5–23.8

10.6±12.3

18.8±12.0

Patients with final diagnosis other than acute coronary syndrome
Mean
Median
Interquartile range

<0.001
6.1

21.1

4.0–9.6

8.7–23.8

Patients with final diagnosis of acute coronary syndrome

0.002

Mean

8.0±15.1

Median

17.1±9.5

4.4

14.9

3.3–5.6

7.4–25.1

Direct discharge from emergency department

233 (47)

62 (12)

Admission to observation unit

153 (30)

301 (60)

Admission to hospital

107 (21)

125 (25)

8 (2)

11 (2)

Repeat visit to emergency department

14

19

Repeat hospitalization

7

7

Interquartile range
Discharge status — no. (%)

<0.001

Left against medical advice
Follow-up for recurrent chest pain within 28 days — no.

0.38

Safety — no.
Undetected acute coronary syndrome

0

0

Periprocedural complications

2

0

0.50

2

6

0.18

Major adverse cardiovascular events at 28 days — no.
* Plus–minus values are means ±SD.

CCTA and after standard evaluation in the emergency department.
In the overall cohort and also in the subgroups with or without a final diagnosis of an
304
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acute coronary syndrome, the mean time to diagnosis was significantly decreased with CCTA as
compared with a standard evaluation. Patients in
the CCTA group were more often directly dis-
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Proportion of Patients Discharged (%)

charged from the emergency department (47%, vs.
12% of patients in the standard-evaluation group;
P<0.001), with fewer admissions to an observation unit.
Safety End Points

Prespecified clinical adverse events were infrequent in this trial (Table 2). No cases of undetected acute coronary syndromes were identified in
either study group. Overall, there were eight major adverse cardiovascular events during the 28day follow-up: six after standard evaluation in
the emergency department (four myocardial infarctions and two cases of unstable angina pectoris for which percutaneous coronary intervention was required) and two after CCTA (one
myocardial infarction and one case of unstable
angina pectoris for which percutaneous coronary
intervention was required) (P = 0.18). In both of
the latter patients, CCTA established clinically significant coronary artery disease during the index
hospitalization, but both patients had negative
stress tests and were initially treated medically.
Two periprocedural complications occurred in the
CCTA group (perioperative bleeding after cardiothoracic surgery for an identified anomalous coronary artery and a transient increase in the creatinine level after CCTA without the need for dialysis
in a patient with a urethral stone and hydronephrosis), and no periprocedural complications
occurred in the standard-evaluation group.
Resource Utilization and Radiation Exposure

Table 3 shows resource utilization. Overall, more
diagnostic testing was performed in the CCTA
group than in the standard-evaluation group
(P<0.001). Both the cumulative rate of invasive
coronary angiography during the index hospitalization and follow-up and the rate of coronary
revascularization were higher among patients in
the CCTA group than among patients in the standard-evaluation group, but the differences were
not significant (P = 0.06 and P = 0.16, respectively)
(Table 3).
Nearly all patients in the CCTA group (484 of
501 patients; 97%), but only 167 of 499 patients
randomly assigned to standard evaluation (33%)
received radiation exposure from an imaging test
or procedure. Hence, cumulative radiation exposure was significantly higher in the CCTA group
(Table 3). The mean radiation exposure from
CCTA was 11.3±5.3 mSv and was lower than that
n engl j med 367;4

100
90
80
CCTA

70
60
8.6 hr

50

26.7 hr

40
30
20

Standard evaluation in
emergency department

10
0

0

6

12

18

24

30

36

42

48

70
77

66
72

57
63

Length of Stay (hr)

No. of Patients in
Emergency
Department
or Hospital
CCTA
501
Standard evaluation 499

404
484

191
403

174
387

159
331

95
135

Figure 2. Length of Stay in the Hospital and Proportion of Patients
Discharged.
The cumulative frequency of discharge from the index visit according to the
length of stay is shown. The horizontal line indicates the median length of
stay in the two study groups, which was significantly different (8.6 hours in
the CCTA group vs. 26.7 hours in the standard-evaluation group, P<0.001).

from single-photon-emission CT (14.1±4.8 mSv,
P<0.001). The 78 patients who underwent CCTA
with the use of an advanced 128-slice, dualsource CT scanner had lower radiation exposure
(6.2±3.8 mSv) than did the remaining patients
(12.3±5 mSv).
Detailed cost data were available in a subgroup
of all 649 patients from five centers (Table 3).
The mean costs of care from the initial visit in
the emergency department through the 28-day
follow-up were similar in the CCTA group and
the group that received standard evaluation in
the emergency department (P = 0.65).

Discussion
This prospective, multicenter, randomized, strategy-controlled trial was designed primarily to assess whether CCTA, incorporated early into an
evaluation strategy for patients presenting to an
emergency department with chest pain suggestive of an acute coronary syndrome, safely improves the efficiency of clinical decision making,
as compared with a standard evaluation in the
emergency department. The cumulative costs of
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Table 3. Resource Utilization, Radiation Exposure, and Costs of Care.*
Variable

Index Visit
CCTA
(N = 501)

Index Plus Follow-up Visit

Standard
Evaluation
(N = 499)

Diagnostic testing — no. of patients (%)†
No testing‡

P Value

CCTA
(N = 501)

Standard
Evaluation
(N = 499)

<0.001

<0.001

9 (2)

109 (22)

9 (2)

89 (18)

1 test

376 (75)

337 (68)

359 (72)

350 (70)

≥2 tests

116 (23)

53 (11)

133 (27)

60 (12)

58 (12)

133 (27)

Functional testing — no. (%)§

P Value

<0.001

<0.001

SPECT

50 (10)

124 (25)

Stress echocardiography

20 (4)

102 (20)

20 (4)

102 (20)

ETT

12 (2)

147 (29)

22 (4)

162 (32)

54 (11)

36 (7)

0.06

59 (12)

40 (8)

0.06

24 (5)

14 (3)

0.14

27 (5)

17 (3)

0.16

Invasive coronary angiography — no. (%)
Intervention — no. (%)
PCI
CABG
Cumulative radiation exposure — mSv/patient¶

5 (1)

4 (1)

0.99

5 (1)

4 (1)

0.99

13.9±10.4

4.7±8.4

<0.001

14.3±10.9

5.3±9.6

<0.001

Costs of care — U.S. dollars‖

<0.001

Emergency department
Mean

2,101±1,070

Median
Interquartile range

2,566±1,323

1,770

2,293

1,435–2,161

1,592–3,583

1,925±6,697

1,308±5,333

4,026±6,792

3,874±5,298

4,289±7,110

4,060±5,452

1,937

2,742

1,946

2,809

1,504–4,057

1,755–3,832

1,514–4,164

1,822–4,060

Hospital

0.19

Mean
Total

0.75

Mean
Median
Interquartile range

0.65

* Plus–minus values are means ±SD. Percentages may not sum to 100 because of rounding. CABG denotes coronary-artery bypass grafting,
ETT exercise treadmill testing, PCI percutaneous coronary intervention, and SPECT single-photon-emission computed tomography.
† Diagnostic testing included CCTA, ETT, SPECT, stress echocardiography, and invasive coronary angiography.
‡ Serial measurement of biomarkers and electrocardiographic testing were not considered as diagnostic tests in this table.
§ At the index visit, functional testing was the second test in the CCTA group and the first test in the standard-evaluation group.
¶ Radiation exposure included exposure from CCTA, SPECT, and invasive coronary angiography.
║
‖ Costs included those for patients discharged directly from the emergency department and those discharged from an observation unit.

diagnostic tests, interventions, and radiation exposure were also evaluated. The average length of
stay in the hospital, the primary end point of the
trial, was significantly reduced in the CCTA
group, as was the time to diagnosis. Furthermore, rates of direct discharge from the emergency department were higher with CCTA than
with a standard evaluation in the emergency department. These results were achieved without
putting patients at greater risk for undetected
acute coronary syndromes and without an increase in the cost of care. However, we observed
306
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increased diagnostic testing in the CCTA group
and increased radiation exposure.
An important consideration when results show
more efficient triage is whether that gain is
achieved at the risk of undetected acute coronary
syndromes. There were no undetected cases of
acute coronary syndromes in either study group,
suggesting that the earlier and greater number
of discharges in the CCTA group did not result in
any missed diagnoses. More major adverse cardiovascular events were observed in the standardevaluation group than in the CCTA group,

nejm.org

july 26, 2012

The New England Journal of Medicine
Downloaded from nejm.org at WASHINGTON UNIV SCH MED MEDICAL LIB on April 26, 2014. For personal use only. No other uses without permission.
Copyright © 2012 Massachusetts Medical Society. All rights reserved.

coronary CT Angiogr aphy for Acute Chest Pain

though the study did not have the statistical
power to support the conclusion that major adverse cardiovascular events may be reduced after
a CCTA-based evaluation.
The prevalence of acute coronary syndromes in
a patient population is an important determinant
of the risk–benefit ratio, given that CCTA is an
advanced diagnostic imaging test that entails the
administration of iodinated contrast material, radiation exposure, and costs. In our study population of patients who were at intermediate risk
for acute coronary syndromes (observed rate of
acute coronary syndromes, 7.5%, vs. 2 and 4% in
previous studies10,11), a greater number of invasive
coronary procedures were performed after CCTA
than after a standard evaluation. Information on
the presence of anatomical coronary artery disease
may influence clinical decision making toward
invasive angiography. This concept is consistent
with recent data suggesting that in a Medicare
population, imaging of the coronary anatomy with
CCTA in a nonemergency setting led to greater use
of downstream testing and procedures, as compared with functional stress testing.12
In this trial, no decrease in total costs for the
index visit and during 28-day follow-up was observed in a subgroup of 649 patients from five of
nine sites in which complete billing data were
available. Long-term outcome data are not available; such data might have allowed a determination of whether CCTA results in fewer repeat
visits to the emergency department and hospitalizations over a longer time course.
Cumulative radiation exposure was higher in
the group randomly assigned to CCTA than in the
standard-evaluation group. Recent data show that
diagnostic-quality CCTA imaging can be performed with exposure of less than 5 mSv in selected patients; this suggests that future studies
could use lower doses of radiation.16,17 Lowerdose radiation should be considered in efforts to
apply this strategy more widely, as well as in
particular groups of patients.
There are several limitations of the present
study and analysis. Enrollment occurred only during weekday hours when all imaging testing was
available with technologists and readers on site.
However, the results of triage decision making
and particularly the timing of decisions to discharge or hospitalize patients would probably be
different if the imaging studies were carried out
during the night, when testing and interpretation
n engl j med 367;4

are not as accessible. Similarly, the results cannot
be generalized to clinical sites that perform a
dedicated accelerated diagnostic protocol18 in the
standard evaluation.
Inherent in the design of any randomized,
comparative-effectiveness trial assessing a testing
procedure is the lack of blinding to the intervention. We acknowledge that there may have been a
bias in decision making toward earlier discharge
in the CCTA group. For both groups of patients,
however, the decision making was left to a large
number of clinicians at the nine sites who were
not directly associated with the study and whose
decisions were subject to the same imperatives to
provide high-quality clinical care and to take into
account medical and legal considerations. Finally,
the results of this study may not be applicable to
populations that we did not study, including patients younger than 40 years of age and those
older than 74 years of age.
In conclusion, in this trial involving patients
with suspected acute coronary syndromes, an
evaluation strategy incorporating early CCTA, as
compared with a standard evaluation strategy,
improved the efficiency of clinical decision making for triage in the emergency department, with
a shorter length of stay in the hospital and more
direct discharges from the emergency department.
This improvement appeared to be accomplished
safely, without putting patients at greater risk for
undetected acute coronary syndromes. There was
increased diagnostic testing and higher radiation
exposure in the CCTA group, with no overall
reduction in the cost of care. These data should
allow providers and patients to make informed
decisions about the use of this technology as an
option for evaluation when symptoms are suggestive of an acute coronary syndrome.
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